Cancer Liver Cancer Liver Cancer Guide Liver Cancer Guide Symptoms Causes Diagnosis Treatment Prevention Coping Caregiving How Liver Cancer Is Treated A look at surgery, liver transplant, and prescription drugs By Colleen Doherty, MD Colleen Doherty, MD Colleen Doherty, MD, is a board-certified internist living with multiple sclerosis. Learn about our editorial process Updated on July 22, 2021 Medically reviewed by Doru Paul, MD Medically reviewed by Doru Paul, MD Doru Paul, MD, is triple board-certified in medical oncology, hematology, and internal medicine. He is an associate professor of clinical medicine at Weill Cornell Medical College and attending physician in the Department of Hematology and Oncology at the New York Presbyterian Weill Cornell Medical Center. Learn about our Medical Expert Board Print Table of Contents View All Table of Contents Surgery Liver Transplant Non-Surgical Procedures Prescriptions Complementary Medicine Frequently Asked Questions Next in Liver Cancer Guide How to Prevent Liver Cancer The treatment of liver cancer depends on the stage of the cancer, as well as a person's underlying liver function. While the preferred treatment is surgical removal of the cancer, many people are not candidates for surgery due to the extent of their disease and/or poor baseline liver health. Besides surgery, other treatment options include liver transplant, ablation therapy, embolization therapy, and prescription medications like targeted therapy, chemotherapy, and immunotherapy. JGI/Tom Grill / Getty Images Surgery Surgical removal of liver cancer is the treatment of choice. The challenge with surgery, however, is that most people with liver cancer also have cirrhosis from long-term liver disease. With limited liver function from cirrhosis (the liver is so scarred), removing even a small part of liver tissue along with the cancer may render a liver functionally inadequate. Moreover, many liver cancers cannot be properly removed because they are too large and/or have spread outside the liver. Evaluation In order to access whether or not a person is a good surgical candidate, a healthcare provider will order an imaging test (like a CT scan or MRI) to evaluate the extent of the cancer, as well as liver function blood tests. The best surgical candidate is someone with a single liver tumor (not multiple) and preserved liver function. If you or a loved one is undergoing liver cancer surgery, it's imperative you review all the risks and possible side effects with your surgeon. In addition, do not be afraid to ask questions and inquire about your surgeon's experience. Liver Cancer Doctor Discussion Guide Get our printable guide for your next healthcare provider's appointment to help you ask the right questions. Download PDF Sign up for our Health Tip of the Day newsletter, and receive daily tips that will help you live your healthiest life. Sign Up You're in! Thank you, {{form.email}}, for signing up. There was an error. Please try again. Possible Side Effects Surgical removal of liver cancer is a major surgery, especially since the liver is rich in blood vessels. This makes bleeding during surgery a major concern. Other potential side effects of surgery include: Infection Blood clots Complications related to anesthesia Pneumonia Your medical team will monitor you in order to minimize these risks, and provide instructions for ways you can minimize risk of complications as well. Liver Transplant Besides surgery, undergoing a liver transplant is another potentially curable treatment option, with the added benefit of treating not only the cancer but the cirrhosis, too. During a liver transplant, a transplant surgeon removes the diseased liver and replaces it with a healthy one from another person. A healthcare provider may recommend a liver transplant if a liver tumor(s) is small or if surgery is not a possibility due to an unhealthy liver. A major obstacle with liver transplants is the limited availability of livers. According to the American Cancer Society, only about 6,500 livers are available for transplant each year, and most of them are used for people with liver problems other than cancer. Possible Side Effects In addition to the possible side effects associated with liver surgery (bleeding, infection, blood clots, anesthesia complications, and pneumonia), there are potential side effects linked to the medications a person needs to take after the transplant. These immune-suppressing medications prevent a person from rejecting their new liver. Because they suppress your immune system, though, people are prone to infections. Other potential side effects of immune-suppressing drugs include: High blood pressureHigh cholesterolKidney problemsDiabetesBone weakening (called osteoporosis) Non-Surgical Procedures For people with liver cancer who are not surgical candidates, ablation and/or embolization therapy may be a treatment option. These therapies shrink and possibly destroy liver tumors. Ablation Therapy Ablation therapy is a non-surgical means of killing cancer cells and is the most frequently utilized therapy in liver cancer care. This procedure entails placing a needle or probe directly into a liver tumor and using various means to kill the cells. The types of ablation therapy are named based on the means used to destroy the cancer cells: Radiofrequency ablation (RFA): High-energy radio waves heat and kill the cancer cellsPercutaneous ethanol (alcohol) ablation: Alcohol is injected into the cancer cellsCryotherapy: Very cold gases are passed through the tumor to freeze the cancer cellsMicrowave ablation: Heat from microwaves is transmitted into the cancer cells As with any procedure, there are risks and potential side effects to undergoing ablation. Some of these include: Bleeding and bruising at the skin site where the needle or probe is insertedDamage to blood vessels in the liver or the surrounding liver tissue if the needle or probe is improperly placedInfection, including liver abscessDamage to the bile duct or other organsTumor seeding (a rare complication in which cancer cells are dispersed along the tract of the needle) Embolization Therapy During embolization, the blood supply to the liver cancer is blocked off so the cancer is "starved" and cannot grow. This treatment option may be used for liver tumors that are large and/or cannot be removed surgically. Sometimes embolization is combined with chemotherapy (called chemoembolization) or radiation (radioembolization). Prescriptions Prescription medications are used to treat advanced or late-stage liver cancer. Targeted therapies are first-line therapy for treating advanced liver cancer, followed by chemotherapy or immunotherapy as a second-line option. Targeted Therapies Targeted drugs work by interfering with substances needed for cancer to grow. An approved first-line therapy for treating un-resectable liver cancer (meaning liver cancer that cannot be removed surgically) is Nexavar (sorafenib), which is a targeted drug that blocks a liver tumor from making new blood vessels. Common side effects of Nexavar include: FatigueRashLoss of appetiteDiarrheaHigh blood pressureHand-foot reaction For people who cannot tolerate Nexavar, or as an alternative first-line therapy, a similar drug called Lenvima (lenvatinib) may be considered. On May 29, 2020, the Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) and Avastin (bevacizumab) as an initial treatment for people with liver cancer that has spread or that can’t be treated with surgery. In the study that led to the approval, called IMbrave150, liver cancer patients treated with atezolizumab and bevacizumab lived substantially longer than those treated with Nexavar. They also lived longer without their cancer getting worse. The most common side effects of Lenvima are: High blood pressureDiarrheaDecreased appetiteWeight lossFatigue Another targeted drug Stivarga (regorafenib) blocks proteins that help liver cancer cells grow. This drug is currently used as a second-line therapy (meaning if Nexavar or Lenvima stop working). Common side effects include: FatigueLoss of appetite and weight lossRash on hands and feetHigh blood pressureFever and infectionsDiarrheaBelly pain Chemotherapy Chemotherapies are drugs that kill cancer cells. While "chemo" is generally taken by mouth or through a vein, in the case of liver cancer, it may be administered directly into the liver through the hepatic artery (called hepatic artery infusion). Depending on the type and dose of chemotherapy given, a person may experience a range of possible side effects like: Loss of hairMouth soresNausea, vomiting, and/or diarrheaWeight loss from a decrease in appetite Since chemo drugs target rapidly dividing cells (cancer cells grow quickly), cells in a person's bone marrow are often destroyed. This may lead to symptoms like easy bruising and bleeding, as well as fatigue and a high risk of infection. Immunotherapy Immunotherapy is a very exciting, evolving treatment option that has changed the face of cancer care. The premise behind immunotherapy is that it stimulates a person's own immune system to attack cancer cells. For liver cancer, the immunotherapy drug Opdivo (nivolumab) works by blocking an immune checkpoint protein called programmed death 1 (PD-1). This protein is deceitfully made by cancer cells to prevent a person's immune system from recognizing it as foreign. So, by blocking PD-1, cancer can then be recognized and attacked. Opdivo is given through the vein, every two weeks. Potential side effects include: Fatigue or weaknessFeverCoughNausea and loss of appetiteItching and skin rashMuscle or joint painConstipation or diarrhea More serious side effects include a reaction to the infusion (similar to an allergic reaction) or an autoimmune reaction, in which a person's own immune system begins attacking healthy organs (for example, the lungs). Complementary Medicine Before using any herb or food, be sure to let your healthcare provider know. This will help prevent any unwanted side effects and interactions. Sho-saiko-to One herbal drug called Sho-saiko-to (also called Xiao Chai Hu Tang), which is a mixture of seven botanicals, including ginseng, ginger, and licorice, has been used to treat chronic hepatitis and cirrhosis. Some research suggests that this herbal drug may also help suppress the development of liver cancer in people with cirrhosis, although its precise mechanism of action is unclear. While Sho-saiko-to is believed to be generally well-tolerated, it can cause lung and liver injury, so should only be taken under the guidance of a healthcare provider. Holy Basil Another herb called Ocimum sanctum L or "Holy Basil" is a plant that contains phytochemicals that promote liver health. It also possesses anti-cancer properties. This green vegetable is sometimes used in Thai cuisines. It has no known side effects. Milk Thistle Silymarin (Silybum marianum), also called milk thistle, is used in some countries (like Germany) as a supportive treatment for chronic liver disease. It's also believed to have anti-cancer properties and has a good safety profile, although it may cause an allergic reaction or mild digestive symptoms. Natural Foods Besides herbs, natural foods may also help protect against liver cancer. Coffee is a rich source of antioxidants and is linked to a reduced risk of both cirrhosis and liver cancer. However, there is no scientific evidence that increasing your current coffee consumption (or starting to drink coffee if you never have) is beneficial. Frequently Asked Questions Who is most at risk of developing liver cancer? Risk factors associated with liver cancer include gender (liver cancer affects men more often than women) and race (Asians and Pacific Islanders are more frequently affected). Other risk factors include hepatitis B or C infection, fatty liver disease, immunosuppression, diabetes, exposure to carcinogens, genetics, and lifestyle choices such as excessive alcohol use and smoking. Can liver cancer be diagnosed early? Liver cancer is difficult to diagnose early because symptoms often do not appear in the earliest stages, but healthcare providers now test people who are at greater risk of developing liver cancer due to long-term cirrhosis. Other reasons that healthcare providers screen for liver cancer include a chronic hepatitis B infection and hereditary hemochromatosis. How to Prevent Liver Cancer 25 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Liu CY, Chen KF, Chen PJ. Treatment of Liver Cancer. Cold Spring Harb Perspect Med. 2015;5(9):a021535. doi:10.1101/cshperspect.a021535 Tsim NC, Frampton AE, Habib NA, Jiao LR. Surgical treatment for liver cancer. World J Gastroenterol. 2010;16(8):927‐933. doi:10.3748/wjg.v16.i8.927 American Cancer Society. About Liver Cancer. cancer.org Lala V, Goyal A, Bansal P, et al. Liver Function Tests. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482489/ Jin S, Fu Q, Wuyun G, Wuyun T. Management of post-hepatectomy complications. World J Gastroenterol. 2013;19(44):7983‐7991. doi:10.3748/wjg.v19.i44.7983 Sauer IM, Bechstein WO, Neuhaus P. Liver transplantation. In: Holzheimer RG, Mannick JA, editors. Surgical Treatment: Evidence-Based and Problem-Oriented. Munich: Zuckschwerdt. Available from: https://www.ncbi.nlm.nih.gov/books/NBK6890/ Wáng YX, De Baere T, Idée JM, Ballet S. Transcatheter embolization therapy in liver cancer: an update of clinical evidences. Chin J Cancer Res. 2015;27(2):96‐121. doi:10.3978/j.issn.1000-9604.2015.03.03 The American Cancer Society medical and editorial content team. Ablation for Liver Cancer American Cancer Society. cancer.org Revel-Mouroz P, Otal P, Jaffro M, et al. Other non-surgical treatments for liver cancer. Rep Pract Oncol Radiother. 2017;22(2):181‐192. doi:10.1016/j.rpor.2017.02.007 Gish RG, Finn RS, Marrero JA. Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma. Gastroenterol Hepatol (N Y). 2013;9(4 Suppl 2):1‐24. American Cancer Society. Targeted Therapy for Liver Cancer Personeni N, Pressiani T, Rimassa L. Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date. J Hepatocell Carcinoma. 2019;6:31‐39. doi:10.2147/JHC.S168953 Finn RS, Qin S, Ikeda M, et al. IMbrave150 Investigators. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745 Personeni N, Pressiani T, Santoro A, Rimassa L. Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications. Drugs Context. 2018;7:212533. doi:10.7573/dic.212533 The American Cancer Society medical and editorial content team. Chemotherapy for Liver Cancer. American Cancer Society. cancer.org Le Grazie M, Biagini MR, Tarocchi M, Polvani S, Galli A. Chemotherapy for hepatocellular carcinoma: The present and the future. World J Hepatol. 2017;9(21):907‐920. doi:10.4254/wjh.v9.i21.907 Li Z, Song W, Rubinstein M, Liu D. Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing. J Hematol Oncol. 2018;11(1):142. doi:10.1186/s13045-018-0684-3 Finkelmeier F, Waidmann O, Trojan J. Nivolumab for the treatment of hepatocellular carcinoma. Expert Rev Anticancer Ther. 2018;18(12):1169‐1175. doi:10.1080/14737140.2018.1535315 Shimizu I. Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. J Gastroenterol Hepatol. 2000;15 Suppl:D84-90. Sharma P, Prakash O, Shukla A, et al. Structure-Activity Relationship Studies on Holy Basil (Ocimum sanctum L.) Based Flavonoid Orientin and its Analogue for Cytotoxic Activity in Liver Cancer Cell Line HepG2. Comb Chem High Throughput Screen. 2016;19(8):656‐666. doi:10.2174/1386207319666160709192801 Mastron JK, Siveen KS, Sethi G, Bishayee A. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review. Anticancer Drugs. 2015;26(5):475‐486. doi:10.1097/CAD.0000000000000211 Koumbi L. Dietary factors can protect against liver cancer development. World J Hepatol. 2017;9(3):119‐125. doi:10.4254/wjh.v9.i3.119 Pham C, Fong TL, Zhang J, Liu L. Striking Racial/Ethnic Disparities in Liver Cancer Incidence Rates and Temporal Trends in California, 1988-2012. J Natl Cancer Inst. 2018;110(11):1259-1269. doi:10.1093/jnci/djy051 Petrick JL, Campbell PT, Koshiol J, et al. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. Br J Cancer. 2018;118(7):1005-1012. doi:10.1038/s41416-018-0007-z American Cancer Society. Can liver cancer be found early? Additional Reading American Cancer Society. (n.d.). Treating Liver Cancer. cancer.org Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018 Mar 31;391(10127):1301-14. Kim JW et al. Ultrasound-guided percutaneous radiofrequency ablation of liver tumors: How we do it safely and completely. Korean J Radiol. 2015 Nov-Dec;16(6):1226-39. Kudo M et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 2 non-inferiority trial. Lancet. 2018 Mar 24;391(10126):1163-73. Waghray A, Murali AR, Menon KVN. Hepatocellular carcinoma: From diagnosis to treatment. World J Hepatol. 2015 May 18;7(8):1020-29. By Colleen Doherty, MD Colleen Doherty, MD, is a board-certified internist living with multiple sclerosis. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit